Funded Research
Since 2003, Cancer Council ACT has contributed $1,984,942 to local cancer research.
Epigenetic regulator H2A.B as a novel target for treatment of Hodgkin Lymphoma.
- Principal Investigator
- Dr Tatiana Soboleva
- Grant Awarded
- 2020-21, $61,265
The nucleolar stress response at the centre of the malignant phenotype.
- Principal Investigator
- Dr Anne Steins
- Grant Awarded
- 2020-21, $64,985
Investigating the role of MYB in Burkitt lymphoma
- Principal Investigator
- Dr Keisuke Horikawa
- Grant Awarded
- 2019-20, $65,000
Targeting cancer metabolism to reduce metastases
- Principal Investigator
- A/Prof Anneke Blackburn
- Grant Awarded
- 2018-19, $65,000
Mechanisms and targets of protein synthesis dysregulation in cancer
- Principal Investigator
- Prof Thomas Preiss
- Grant Awarded
- 2016-2019, $600,000
How exercise prevents obesity-related hepatocellular carcinoma: insights for chemoprevention of liver cancer
- Principal Investigator
- Prof Geoffrey Farrell
- Grant Awarded
- 2016-2018, $200,000
Development of broad spectrum, non-genotoxic cancer treatments for acute myeloid leukaemias and multiple myeloma
- Principal Investigator
- Prof Ross Hannan and A/Prof Anneke Blackburn
- Grant Awarded
- 2015-2018, $340,000
Towards repurposing existing antiretroviral drugs as anticancer agents for cancer therapy
- Principal Investigator
- Dr Danny Rangasamy, The Australian National University
- Grant Awarded
- 2014-15, $65,000
Understanding and targeting metabolic regulators of cancer cell proliferation and cell death.
- Principal Investigator
- Dr Anneke Blackburn, The Australian National University
- Grant Awarded
- 2013-14, $60,000
Novel histone demethylase inhibitors: potential treatment against cancer metastasis and relapse by targeting cancer stem cells
- Principal Investigator
- A/Prof Sudha Rao, University of Canberra
- Grant Awarded
- 2012-13, $45,164
A new plasmid DNA delivery system - for vaccine development and cancer immunotherapy
- Principal Investigator
- Dr J Altin, The Australian National University
- Grant Awarded
- 2011-12, $37,000
Chromosome condensation and the regulation of cell development
- Principal Investigator
- Dr A Fahrer, The Australian National University
- Grant Awarded
- 2010-11, $50,000
Dichloroacetate: a novel anti-cancer agent
- Principal Investigator
- Dr Anneke Blackburn, The Australian National University
- Grant Awarded
- 2009-10, $50,000
Carers of Cancer Patients: A sociological understanding of their emotional and support service experiences
- Principal Investigator
- Rebecca Olson, PhD candidate, The Australian National University
- Grant Awarded
- 2008-09, $9,390
Understanding the role of Kleisin beta, a subunit of the condensin II complex, in T cell differentiation
- Principal Investigator
- Dr A Fahrer, The Australian National University
- Grant Awarded
- 2008-09, $50,000
Carers of Cancer Patients: Understanding their support service needs.
- Principal Investigator
- Rebecca Olson, PhD candidate, The Australian National University
- Grant Awarded
- 2007-08, $4,695
Understanding the role of Kleisin beta, a subunit of the condensin II complex, in T cell differentiation.
- Principal Investigator
- Dr A Fahrer, The Australian National University
- Grant Awarded
- 2006-07, $42,500
Cancer clinical trials at The Canberra Hospital
- Principal Investigator
- Dr D Yip, The Canberra Hospital
- Grant Awarded
- 2007-08, $44,000
A clinical trials cancer research program in the ACT
- Principal Investigator
- Dr D Yip, Dr P Craft, A/Prof R Stuart-Harris, Dr D Leong, Dr A Davis, The Canberra Hospital
- Grant Awarded
- 2005-06, $33,700
Towards a cancer prevention program for the ACT and SE NSW region. A background paper and mapping exercise.
- Principal Investigator
- Ms N. Druhan-McGinn
- Grant Awarded
- 2004-06, $31,243
Coping styles and severity of toxicity from adjuvant chemotherapy for early breast cancer
- Principal Investigator
- A/Prof R Stuart-Harris, The Canberra Hospital and Prof D Byrne, The Australian National University
- Grant Awarded
- 2003-06, $66,000